![N-[(5E)-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene]methanamine hydrobromide (1:1)](https://static.cymitquimica.com/cas-image/395068-n-5e-23-diphenyl-124-thiadiazol-5-2h-ylidene-methanamine-hydrobromide-1-1.png)
CAS: 70375-43-8 - N-[(5E)-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene]methanamine hydrobromide (1:1)
Fórmula:C15H14BrN3S
InChI:InChI=1/C15H13N3S.BrH/c1-16-15-17-14(12-8-4-2-5-9-12)18(19-15)13-10-6-3-7-11-13;/h2-11H,1H3;1H/b16-15+;
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | SCH-202676 REF: TR-S200038CAS: 70375-43-8 | - - - | 5.339,00 € | Mar 07 Ene 25 |
 | SCH-202676 REF: 3D-VCA37543CAS: 70375-43-8 | Min. 95% | A consultar | Mar 07 Ene 25 |
 | SCH-202676 HBr REF: TM-T24770CAS: 70375-43-8 | 98% | 1.386,00 €~2.320,00 € | Mar 14 Ene 25 |
| SCH-202676 Hydrobromide REF: TR-S199935CAS: | - - - | - - - | Producto descatalogado |
SCH-202676
Producto controladoCAS:70375-43-8
Fórmula:
C15H13N3S
Forma y color:
Neat
Peso molecular:
267.349
Ref: TR-S200038
| 500mg | 5.339,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
SCH-202676
CAS:70375-43-8
SCH-202676 is a small molecule that exhibits inhibitory properties against the epidermal growth receptor (EGFR) …
Fórmula:
C15H14BrN3S
Pureza:
Min. 95%
Peso molecular:
348.3 g/mol
Ref: 3D-VCA37543
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
SCH-202676 HBr
CAS:70375-43-8
SCH-202676 HBr is an allosteric agonist. It also an GPCR antagonist.
Fórmula:
C15H13N3S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
267.35
Ref: TM-T24770
| 25mg | 1.386,00 € | ||
| 50mg | 1.838,00 € | ||
| 100mg | 2.320,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
SCH-202676 Hydrobromide
Applications SCH-202676 Hydrobromide acts as a reversible inhibitor with agonist and antagonist binding to G-protein-coupled …
Fórmula:
C15H14BrN3S
Forma y color:
White to Pale Beige Solid
Peso molecular:
348.261
Ref: TR-S199935
| 5mg | Descatalogado | Solicitar información |
